Weekly may be as efficacious as daily folic acid supplementation in improving folate status and lowering serum homocysteine concentrations in Guatemalan women

Journal of Nutrition

Volumn 138, Issue 8, 2008, Pages 1491-1498

  Nguyen, Phuong ^a   Grajeda, Ruben ^a,b   Melgar, Paul ^a,c   Marcinkevage, Jessica ^a   Flores, Rafael ^a   Martorell, Reynaldo ^a  

^a EMORY UNIVERSITY   (United States)

^b PAN AMERICAN HEALTH ORGANIZATION   (United States)

^c Institute of Nutrition of Central America and Panama Guatemala   (Guatemala)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; IRON; ZINC;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOSAGE SCHEDULE COMPARISON; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHROCYTE LEVEL; FEMALE; FOLIC ACID BLOOD LEVEL; GUATEMALA; HUMAN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 49449113311     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.1093/jn/138.8.1491     Document Type: Article

References (55)

1. Murray CJL, Lopez AD. Global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Vol. 1. The global burden of disease and injury. Cambridge (MA): Harvard School of Public Health; 1996.
2. Acevedo CR, Anzueto ER, Mendez AG, Ramirez FM. Prevalencia de anomalías congénitas mayores externas, en recién nacidos atendidos en hospitales nacionales y regionales de Guatemala. (Durante el periodo comprendido del año 2001 al 2003) [undergraduate graduation thesis]. Guatemala City (Guatemala): School of Medicine, Universidad de San Carlos de Guatemala; 2004.
3. Cifuentes G. Perfil epidemiológico de las anomalías del tubo neural en Guatemala, Enero-Diciembre de 2000 [undergraduate graduation thesis]. Guatemala City (Guatemala): School of Medicine, Universidad San Carlos de Guatemala; 2002.
4. Rogers LM, Boy E, Miller JW, Green R, Sabel JC, Allen LH. High prevalence of cobalamin deficiency in Guatemalan schoolchildren: associations with low plasma holotranscobalamin II and elevated serum methylmalonic acid and plasma homocysteine concentrations. Am J Clin Nutr. 2003;77:433-40.
5. Casterline JE, Allen LH, Ruel MT. Vitamin B-12 deficiency is very prevalent in lactating Guatemalan women and their infants at three months postpartum. J Nutr. 1997;127:1966-72.
6. Malmad JL. An evaluation of the potential impact of folic acid fortification of wheat flour on folic acid consumption and blood folate concentrations in women of reproductive age from periurban Guatemala city [master's thesis]. Atlanta: Rollins School of Public Heath, Emory University; 2006.
7. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, Kirke P. Folic acid metabolism and mechanisms of neural tube defects. Ciba Found Symp. 1994;181:180-7.
8. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-55.
9. Clarke R, Lewington S. Homocysteine and coronary heart disease. Semin Vasc Med. 2002;2:391-9.
10. Cotter AM, Molloy AM, Scott JM, Daly SF. Elevated plasma homocysteine in early pregnancy: a risk factor for the development of severe preeclampsia. Am J Obstet Gynecol. 2001;185:781-5.
11. Vollset SE, Refsum H, Irgens LM, Emblem BM, Tverdal A, Gjessing HK, Monsen AL, Ueland PM. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study. Am J Clin Nutr. 2000;71:962-8.
12. Steegers-Theunissen RP, Boers GH, Trijbels FJ, Finkelstein JD, Blom HJ, Thomas CM, Borm GF, Wouters MG, Eskes TK. Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism. 1994;43:1475-80.
13. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, Weir DG, Scott JM. Homocysteine metabolism in pregnancies complicated by neuraltube defects. Lancet. 1995;345:149-51.
14. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet. 1991;338:131-7.
15. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, Mulinare J, Zhao P, Wong LY, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med. 1999;341:1485-90.
16. Adank C, Green TJ, Skeaff CM, Briars B. Weekly high-dose folic acid supplementation is effective in lowering serum homocysteine concentrations in women. Ann Nutr Metab. 2003;47:55-9.
17. Norsworthy B, Skeaff CM, Adank C, Green TJ. Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr. 2004;58:548-54.
18. Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. Washington, DC: National Academy Press; 2001.
19. Venn BJ, Mann JI, Williams SM, Riddell LJ, Chisholm A, Harper MJ, Aitken W, Rossaak JI. Assessment of three levels of folic acid on serum folate and plasma homocysteine: a randomised placebo-controlled double-blind dietary intervention trial. Eur J Clin Nutr. 2002;56:748-54.
20. Daly S, Mills JL, Molloy AM, Conley M, Lee YJ, Kirke PN, Weir DG, Scott JM. Minimum effective dose of folic acid for food fortification to prevent neural-tube defects. Lancet. 1997;350:1666-9.
21. Daly S, Mills JL, Molloy AM, Conley M, McPartlin J, Lee YJ, Young PB, Kirke PN, Weir DG, et al. Low-dose folic acid lowers plasma homocysteine levels in women of child-bearing age. QJM. 2002;95:733-40.
22. Ward M, McNulty H, McPartlin J, Strain JJ, Weir DG, Scott JM. Plasma homocysteine, a risk factor for cardiovascular disease, is lowered by physiological doses of folic acid. QJM. 1997;90:519-24.
23. Solomons NW. Guatemala introduces once-a-week supplementation. Nutriview. 2003;3:7.
24. Rodriguez MM, Mendez H, Torun B, Schroeder D, Stein AD. Validation of a semi-quantitative food-frequency questionnaire for use among adults in Guatemala. Public Health Nutr. 2002;5:691-9.
25. Tamura T, editor. Microbiological assay of folates in folic acid metabolism in health and disease. New York: John Wiley & Sons, Inc.; 1990.
26. O'Broin JD, Temperley IJ, Scott JM. Erythrocyte, plasma, and serum folate: specimen stability before microbiological assay. Clin Chem. 1980;26:522-4.
27. CDC. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III) 1988-94. Atlanta: CDC, U.S. Department of Health and Human Service; 1998.
28. Araki A, Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr. 1987;422:43-52.
29. Gwatkin DR, Rustein S, Johnsin K, Pande RP, Wagstaff A. Socioeconomic differences in health, nutrition, and population in Bangladesh. Washington, DC: The World Bank's Health and Population Advisory Service; 2000.
30. Maluccio JA, Murphy A, Yount KM. Research note: a socioeconomic index for the INCAP Longitudinal Study 1969-77. Food Nutr Bull. 2005;26:S120-4.
31. Kung-Yee L, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika. 1986;73:13-22.
32. SAS. SAS, the power to know. SAS Institue Inc.; 2002-2004.
33. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PW, Belanger AJ, O'Leary DH, Wolf PA, Schaefer EJ, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-91.
34. Pfeiffer CM, Caudill SP, Gunter EW, Osterloh J, Sampson EJ. Biochemical indicators of B vitamin status in the US population after folic acid fortification: results from the National Health and Nutrition Examination Survey 1999-2000. Am J Clin Nutr. 2005;82:442-50.
35. Pfeiffer CM, Johnson CL, Jain RB, Yetley EA, Picciano MF, Rader JI, Fisher KD, Mulinare J, Osterloh JD. Trends in blood folate and vitamin B-12 concentrations in the United States, 1988-2004. Am J Clin Nutr. 2007;86:718-27.
36. Milne DB, Canfield WK, Mahalko JR, Sandstead HH. Effect of oral folic acid supplements on zinc, copper, and iron absorption and excretion. Am J Clin Nutr. 1984;39:535-9.
37. Simmer K, Iles CA, James C, Thompson RP. Are iron-folate supplements harmful? Am J Clin Nutr. 1987;45:122-5.
38. Ghishan FK, Said HM, Wilson PC, Murrell JE, Greene HL. Intestinal transport of zinc and folic acid: a mutual inhibitory effect. Am J Clin Nutr. 1986;43:258-62.
39. Hansen M, Samman S, Madsen LT, Jensen M, Sorensen SS, Sandstrom B. Folic acid enrichment of bread does not appear to affect zinc absorption in young women. Am J Clin Nutr. 2001;74:125-9.
40. Butterworth CE Jr, Hatch K, Cole P, Sauberlich HE, Tamura T, Cornwell PE, Soong SJ. Zinc concentration in plasma and erythrocytes of subjects receiving folic acid supplementation. Am J Clin Nutr. 1988;47:484-6.
41. Green TJ, Skeaff CM, Whiting SJ, Gibson RS. Effect of folic acid supplementation on plasma zinc concentrations of young women. Nutrition. 2003;19:522-3.
42. Kauwell GP, Bailey LB, Gregory JF III, Bowling DW, Cousins RJ. Zinc status is not adversely affected by folic acid supplementation and zinc intake does not impair folate utilization in human subjects. J Nutr. 1995;125:66-72.
43. Intorre F, Polito A, Andriollo-Sanchez M, Azzini E, Raguzzini A, Toti E, Zaccaria M, Catasta G, Meunier N, et al. Effect of zinc supplementation on vitamin status of middle-aged and older European adults: the ZENITH study. Eur J Clin Nutr. 2007; Jul 11.
44. Yajnik CS, Lubree HG, Thuse NV, Ramdas LV, Deshpande SS, Deshpande VU, Deshpande JA, Uradey BS, Ganpule AA, et al. Oral vitamin B12 supplementation reduces plasma total homocysteine concentration in women in India. Asia Pac J Clin Nutr. 2007;16:103-9.
45. Eussen SJ, de Groot LC, Joosten LW, Bloo RJ, Clarke R, Ueland PM, Schneede J, Blom HJ, Hoefnagels WH, et al. Effect of oral vitamin B-12 with or without folic acid on cognitive function in older people with mild vitamin B-12 deficiency: a randomized, placebo-controlled trial. Am J Clin Nutr. 2006;84:361-70.
46. Ueland PM, Refsum H, Stabler SP, Malinow MR, Andersson A, Allen RH. Total homocysteine in plasma or serum: methods and clinical applications. Clin Chem. 1993;39:1764-79.
47. Imhoff-Kunsch B, Flores R, Dary O, Martorell R. Wheat flour fortification is unlikely to benefit the neediest in Guatemala. J Nutr. 2007;137:1017-22.
48. Dary O. Food fortification successful in Central America. Nutriview. 2003;3:2-3.
49. Viteri FE, Berger J. Importance of pre-pregnancy and pregnancy iron status: can long-term weekly preventive iron and folic acid supplementation achieve desirable and safe status? Nutr Rev. 2005;63:S65-76.
50. Kim YI. Role of folate in colon cancer development and progression. J Nutr. 2003;133:S3731-9.
51. Kim YI. Folate and colorectal cancer: an evidence-based critical review. Mol Nutr Food Res. 2007;51:267-92.
52. Mason JB, Dickstein A, Jacques PF, Haggarty P, Selhub J, Dallal G, Rosenberg IH. A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev. 2007;16:1325-9.
53. Marasas WF, Riley RT, Hendricks KA, Stevens VL, Sadler TW, Gelineau-van Waes J, Missmer SA, Cabrera J, Torres O, et al. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr. 2004;134:711-6.
54. Meredith FI, Torres OR, Saenz de Tejada S, Riley RT, Merrill AH Jr. Fumonisin B1 and hydrolyzed fumonisin B1 (AP1) in tortillas and nixtamalized corn (Zea mays L.) from two different geographic locations in Guatemala. J Food Prot. 1999;62:1218-22.
55. Gibson RS. Assessment of folate and vitamin B12 status. In: Principles of nutritional assessment. New York: Oxford University Press; 2005.